PHOENIX -- (Business Wire)

Today Esio Water & Beverage Development Corp. (OTC:ESWB) ("ESIO") announced that on October 15, 2016 it entered into a non-binding Letter of Intent with iMetabolic, Inc., a Nevada corporation ("iMet"). The Letter of Intent provides the basic terms for ESIO to acquire iMet pursuant to a share exchange (the "Exchange") whereby ESIO will issue 60,000,000 shares of its common stock to the shareholders of iMet on a prorata basis. The Letter of Intent contemplates closing the Exchange before November 30, 2014, subject to completion of the parties' due diligence review and iMet's audit and the approval of iMet's shareholders.

iMet has formulated a group of specially designed nutrition and weight reduction supplements, including pills, food sticks, powders and drinks. These products are based upon and refined from products previously sold by iMet's licensor, Dr. Kent Sasse. Dr. Sasse has a national reputation as an expert on nutrition and weight reduction.

Andrew Ecclestone, Chairman of ESIO, said "The Board has made an exhaustive search for an acquisition candidate and has chosen this opportunity with iMetabolic. We feel this proposed transaction is in the best interests of our shareholders.”

Notice About Forward-Looking Statements

This news release may contain "forward-looking statements", as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.Statements in this press release that are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future, including but not limited to, the accomplishment of any of our plans listed for any acquisitions, production, marketing, products or product sales, and the timeliness within which such items may be accomplished, as referred to in this news release.

Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with acquisitions, product development and sale.These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations, and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and that which is made publicly available by us from time to time.

Contacts:

Esio Water & Beverage Development Corp.
Andrew Ecclestone, 866-545-4875

Source: Esio Water & Beverage Development Corp.